Nutriband Inc.
- NTRB
- NASDAQ
- Biotechnology
- Transdermal Drug Delivery
- Opioid Abuse-Deterrent
$6.00
Today −3.54%Quote Oct 19, 2026, 08:00 PM UTC
−26.20%over the last month
Max drawdown −34.9%From 1-month high −33.3%3 months +94.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Nutriband
Nutriband Inc. specializes in developing a diverse range of pharmaceutical products delivered via transdermal patches. The company's most advanced program centers on AVERSA fentanyl, an innovative fentanyl transdermal system engineered to prevent abuse.
Where the money comes from
Q1 2022 revenue $477,922
- TransdermalPatchesMember$401,99084.1%
- ContractServicesMember$75,93215.9%
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
13
Founded
2016
Market value
$72.9M
Quote Oct 19
Floor
$5.78
3.7% below price
Resistance
$6.01
0.2% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NTRBPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free